Morgan Stanley
BDSI

Morgan Stanley’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Morgan Stanley’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-247,561
Closed -$768K – 8419
2021
Q4 		$768K Buy
247,561
+37,484
+18% +$126K ﹤0.01% 5265
2021
Q3 		$759K Buy
210,077
+106,586
+103% +$402K ﹤0.01% 5238
2021
Q2 		$372K Buy
103,491
+79,903
+339% +$282K ﹤0.01% 5704
2021
Q1 		$92K Sell
23,588
-61,408
-72% -$254K ﹤0.01% 6070
2020
Q4 		$357K Buy
84,996
+57,804
+213% +$223K ﹤0.01% 5268
2020
Q3 		$102K Sell
27,192
-43,986
-62% -$187K ﹤0.01% 5431
2020
Q2 		$311K Buy
71,178
+20,142
+39% +$90.5K ﹤0.01% 4860
2020
Q1 		$193K Sell
51,036
-1,485,802
-97% -$7.3M ﹤0.01% 4880
2019
Q4 		$9.71M Buy
1,536,838
+749,449
+95% +$4.41M ﹤0.01% 2465
2019
Q3 		$3.31M Buy
787,389
+765,766
+3,541% +$3.27M ﹤0.01% 3321
2019
Q2 		$101K Sell
21,623
-1,726,429
-99% -$8.04M ﹤0.01% 5325
2019
Q1 		$9.26M Buy
1,748,052
+1,721,129
+6,393% +$7.86M ﹤0.01% 2107
2018
Q4 		$99K Sell
26,923
-64,072
-70% -$225K ﹤0.01% 5566
2018
Q3 		$255K Sell
90,995
-31,388
-26% -$88.1K ﹤0.01% 5341
2018
Q2 		$361K Sell
122,383
-17,652
-13% -$41.9K ﹤0.01% 5287
2018
Q1 		$315K Buy
140,035
+1,200
+0.9% +$2.81K ﹤0.01% 5260
2017
Q4 		$410K Buy
138,835
+5,454
+4% +$15.1K ﹤0.01% 5082
2017
Q3 		$393K Buy
133,381
+11,510
+9% +$35.1K ﹤0.01% 5017
2017
Q2 		$341K Sell
121,871
-37,658
-24% -$79.5K ﹤0.01% 5033
2017
Q1 		$303K Sell
159,529
-171,059
-52% -$330K ﹤0.01% 5108
2016
Q4 		$578K Buy
330,588
+27,729
+9% +$56.6K ﹤0.01% 4843
2016
Q3 		$818K Buy
302,859
+209,967
+226% +$533K ﹤0.01% 4181
2016
Q2 		$219K Sell
92,892
-60,052
-39% -$166K ﹤0.01% 4889
2016
Q1 		$494K Buy
152,944
+67,861
+80% +$251K ﹤0.01% 4452
2015
Q4 		$407K Sell
85,083
-25,755
-23% -$146K ﹤0.01% 4683
2015
Q3 		$616K Buy
110,838
+8,500
+8% +$62.7K ﹤0.01% 4478
2015
Q2 		$814K Buy
102,338
+16,165
+19% +$139K ﹤0.01% 4355
2015
Q1 		$905K Buy
86,173
+46,571
+118% +$636K ﹤0.01% 4207
2014
Q4 		$476K Buy
39,602
+1,059
+3% +$16.1K ﹤0.01% 4697
2014
Q3 		$659K Sell
38,543
-1,487
-4% -$21.6K ﹤0.01% 4381
2014
Q2 		$483K Sell
40,030
-28,662
-42% -$272K ﹤0.01% 4601
2014
Q1 		$580K Buy
68,692
+65,298
+1,924% +$527K ﹤0.01% 4447
2013
Q4 		$20K Sell
3,394
-15,555
-82% -$80.2K ﹤0.01% 5873
2013
Q3 		$103K Buy
18,949
+4,856
+34% +$23.3K ﹤0.01% 5082
2013
Q2 		$57K Buy
+14,093
New +$66.1K ﹤0.01% 5187

Other funds holding BDSI

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $205M AUM 41.7% 1-Year Est. Return

Morgan Stanley's BDSI Position: Q1 2022 in Review

Morgan Stanley sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 247,561 shares — an estimated $768K sold.

Morgan Stanley first reported a position in BDSI in Q2 2013 and held it in 35 quarters. The position peaked at $9.71M in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Morgan Stanley reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Morgan Stanley sold 247,561 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $768K.
  • Morgan Stanley first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 35 quarters.
  • Morgan Stanley's BioDelivery Sciences International, Inc. position peaked at $9.71M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.